Kcl B. Braun

Potassium Chloride, the active ingredient in Kcl B. Braun, is an electrolyte supplement presented as a solution for injection for intravenous use. It replaces potassium in patients with hypokalemia and corrects electrolyte imbalance in clinical settings.

GNH USA supplies Kcl B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kcl B. Braun is used to address disorders of potassium balance and related electrolyte disturbances.

Hypokalemia: restores normal serum potassium levels in patients with low potassium. Potassium supplementation: provides essential potassium ions during peri‑operative or critical‑care management. Electrolyte imbalance: corrects overall electrolyte disturbances when potassium is deficient.

Adverse reactions may occur with intravenous potassium chloride administration.

Common Side Effects: - Pain or irritation at the injection site - Phlebitis or vein inflammation - Nausea or mild gastrointestinal discomfort - Transient hypotension during rapid infusion - Mild muscle weakness

Serious or Rare Side Effects: - Hyperkalemia leading to cardiac arrhythmias - Severe bradycardia or cardiac arrest - Anaphylactoid reactions - Tissue necrosis if extravasation occurs - Severe electrolyte disturbances such as metabolic acidosis

When using Kcl B. Braun, clinicians should observe several safety measures.

Monitor serum potassium: check levels before and during infusion. Use infusion pump: control rate to avoid rapid administration. Avoid rapid bolus: limit infusion to recommended maximum rates. Assess renal function: adjust dose in impaired clearance. Contraindicated in hyperkalemia: do not administer when serum potassium is already elevated. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride can interact with several medications that affect potassium balance.

Major Interactions (Avoid): - ACE inhibitors: may cause additive hyperkalemia. - Angiotensin II receptor blockers: increase risk of elevated potassium. - Potassium‑sparing diuretics (e.g., spironolactone): potentiate hyperkalemia. - NSAIDs: reduce renal potassium excretion, raising serum levels. - Trimethoprim‑sulfamethoxazole: can raise potassium concentrations.

Moderate Interactions (Monitor Closely): - Digoxin: hyperkalemia may enhance digoxin toxicity. - Beta‑blockers: monitor cardiac rhythm if potassium rises. - Insulin: may mask hypokalemia symptoms. - Corticosteroids: can affect potassium distribution. - Lithium: concurrent use may alter lithium clearance.